A detailed history of Gluskin Sheff & Assoc Inc transactions in Danaher Corp stock. As of the latest transaction made, Gluskin Sheff & Assoc Inc holds 19,222 shares of DHR stock, worth $4.39 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares
19,222
Previous 19,222 -0.0%
Holding current value
$4.39 Million
Previous $4.8 Million 11.27%
% of portfolio
0.66%
Previous 0.58%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$235.51 - $267.98 $29,674 - $33,765
126 Added 0.66%
19,222 $4.8 Million
Q1 2024

May 15, 2024

SELL
$224.58 - $256.19 $337,094 - $384,541
-1,501 Reduced 7.29%
19,096 $4.77 Million
Q4 2023

Feb 14, 2024

SELL
$185.1 - $233.13 $1.13 Million - $1.42 Million
-6,100 Reduced 22.85%
20,597 $4.76 Million
Q3 2023

Nov 14, 2023

SELL
$233.08 - $265.59 $850,975 - $969,669
-3,651 Reduced 12.03%
26,697 $6.62 Million
Q2 2023

Aug 14, 2023

SELL
$224.99 - $256.14 $543,125 - $618,321
-2,414 Reduced 7.37%
30,348 $7.28 Million
Q1 2023

May 15, 2023

SELL
$239.75 - $277.0 $556,939 - $643,471
-2,323 Reduced 6.62%
32,762 $8.26 Million
Q4 2022

Feb 14, 2023

BUY
$241.42 - $282.29 $123,124 - $143,967
510 Added 1.48%
35,085 $9.31 Million
Q3 2022

Nov 14, 2022

BUY
$247.06 - $1507.4 $746,862 - $4.56 Million
3,023 Added 9.58%
34,575 $8.93 Million
Q2 2022

Aug 15, 2022

SELL
$237.11 - $299.66 $102,431 - $129,453
-432 Reduced 1.35%
31,552 $8 Million
Q1 2022

May 16, 2022

BUY
$257.27 - $315.76 $1.61 Million - $1.98 Million
6,266 Added 24.36%
31,984 $9.38 Million
Q4 2021

Feb 14, 2022

BUY
$292.08 - $329.01 $1.22 Million - $1.37 Million
4,177 Added 19.39%
25,718 $8.46 Million
Q3 2021

Nov 12, 2021

BUY
$272.21 - $332.43 $8,438 - $10,305
31 Added 0.14%
21,541 $6.56 Million
Q2 2021

Aug 13, 2021

SELL
$225.08 - $271.69 $1.31 Million - $1.58 Million
-5,830 Reduced 21.32%
21,510 $5.77 Million
Q1 2021

May 14, 2021

SELL
$212.38 - $245.9 $868,846 - $1.01 Million
-4,091 Reduced 13.02%
27,340 $6.15 Million
Q4 2020

Feb 16, 2021

SELL
$212.5 - $245.46 $22,950 - $26,509
-108 Reduced 0.34%
31,431 $6.98 Million
Q3 2020

Nov 12, 2020

SELL
$177.16 - $215.33 $91,768 - $111,540
-518 Reduced 1.62%
31,539 $6.79 Million
Q2 2020

Aug 11, 2020

SELL
$128.7 - $176.83 $1.26 Million - $1.73 Million
-9,800 Reduced 23.41%
32,057 $5.67 Million
Q1 2020

May 13, 2020

BUY
$121.39 - $169.05 $66,764 - $92,977
550 Added 1.33%
41,857 $5.79 Million
Q4 2019

Feb 12, 2020

SELL
$133.47 - $153.48 $36,971 - $42,513
-277 Reduced 0.67%
41,307 $6.21 Million
Q3 2019

Nov 08, 2019

BUY
$135.4 - $146.47 $5.63 Million - $6.09 Million
41,584 New
41,584 $6.01 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $166B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Gluskin Sheff & Assoc Inc Portfolio

Follow Gluskin Sheff & Assoc Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gluskin Sheff & Assoc Inc, based on Form 13F filings with the SEC.

News

Stay updated on Gluskin Sheff & Assoc Inc with notifications on news.